Condition: Clonal Mast Cell Disease · KIT D816V Mutation · Suspected KITD816V Mutated Clonal Mast Cell Disease · Sponsor: Blueprint Medicines Corporation
This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.
This description comes directly from the study's public registry record.
Blueprint Medicines · +1-888-258-7768 · medinfo@blueprintmedicines.com
Blueprint Medicines, EU Contact · +31 85 064 4001 · medinfoeurope@blueprintmedicines.com
Always discuss trial participation with your own doctor first.
| AllerVie Clinical Research | Birmingham, Alabama, United States | Recruiting |
| O'Neal Comprehensive Cancer Center at the UAB | Birmingham, Alabama, United States | Recruiting |
| Kaiser Permanente San Diego | San Diego, California, United States | Recruiting |
| Allergy & Asthma Clinical Research of the Bay Area | Walnut Creek, California, United States | Recruiting |
| Allergy, Asthma, & Immunology Associates of Tampa Bay | Tampa, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Northwestern Medicine Allergy and Immunology | Chicago, Illinois, United States | Recruiting |
| Midwest Allergy Sinus Asthma | Normal, Illinois, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Tulane University School of Medicine | New Orleans, Louisiana, United States | Recruiting |
| AllerVie Health | Glenn Dale, Maryland, United States | Recruiting |
| Barnes-Jewish West County Hospital | St Louis, Missouri, United States | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07143669